Kenneth A Jamerson
Frederick G L Huetwell Collegiate Professor of Cardiovascular Medicine and Professor of Internal Medicine
Internal Medicine/Division of Cardiovascular Medicine
1500 E. Medical Center Dr., Frankel Cardiovascular Center, #2722G
Ann Arbor, MI 48109
[email protected]

Available to mentor
Kenneth A Jamerson
Professor
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
    • Qualifications
    • Sabbatical Leave
      Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, 2008
    • Fellow
      American Heart Association Summer Course on Cardiovascular Epidemiology, United States, 1993
    • Fellow
      University of Michigan Medical School, Internal Medicine, Division of Hypertension, 1990
    • House Officer
      University of Michigan Medical School, Internal Medicine, 1989
    • BS
      University of Michigan–Ann Arbor, Ann Arbor, 1982
    Center Memberships
    • Center Member
      Samuel and Jean Frankel Cardiovascular Center
    Research Overview

    Dr. Jamerson’s basic research addresses the role of sympathetic tone on the metabolism of glucose in human skeletal muscle. Current clinical research focuses on hypertensive nephropathy; non-invasive hemodynamic assessment of organ function and damage in the natural history of hypertension; and insulin resistance in hypertension.

    Recent Publications See All Publications
    • Journal Article
      ACHIEVED SYSTOLIC BLOOD PRESSURE BELOW 130 MMHG PRESERVES KIDNEY FUNCTION IN DIABETIC AND NON-DIABETIC HYPERTENSIVE PATIENTS WITHOUT CARDIAC HYPERTROPHY
      Olsen E, Soraas CL, Schmieder RE, Jamerson K, Macdonald T, Mancia G, Heimark S, Mehlum MH, Mariampillai J, Liestol K, Larstorp AC, Hoieggen A, Kjeldsen SE, Rostrup M, Mo R, Julius S, Weber MA. Journal of Hypertension, 2024 May; 42 (Suppl 1): e114 DOI:10.1097/01.hjh.0001020452.94022.11
    • Journal Article
      ACHIEVED SYSTOLIC BLOOD PRESSURE BELOW 130 MMHG PRESERVES KIDNEY FUNCTION IN HIGH-RISK HYPERTENSIVE PATIENTS WITHOUT CARDIAC HYPERTROPHY BUT WITH PROTEINURIA
      Olsen E, Soraas C, Schmieder R, Jamerson K, Macdonald T, Mancia G, Heimark S, Mehlum MH, Mariampullai J, Liestol K, Larstorp AC, Hoieggen A, Kjeldsen SE, Rostrup M, Mo R, Julius S, Weber MA. Journal of Hypertension, 2024 May; 42 (Suppl 1): e12 - e13. DOI:10.1097/01.hjh.0001019436.18284.79
    • Journal Article
      Cardiovascular Protection Beyond Blood Pressure-Lowering Redux: The ACCOMPLISH trial.
      Kaciroti N, Jamerson KA, Brook RD. Hypertension, 2024 Mar; 81 (3): e13 - e15. DOI:10.1161/HYPERTENSIONAHA.123.22425
      PMID: 38354269
    • Journal Article
      Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials.
      Flack JM, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Adler SG, Fried L, Jamerson K, Toto R, Brinker M, Farjat AE, Kolkhof P, Lawatscheck R, Joseph A, Bakris GL, FIDELIO-DKD and FIGARO-DKD Investigators . Kidney Med, 2023 Dec; 5 (12): 100730 DOI:10.1016/j.xkme.2023.100730
      PMID: 38046911
    • Journal Article
      Worse Blood Pressure Levels and Control During Nonsummer Months in Rigorously Treated Patients With Hypertension: The ACCOMPLISH Trial.
      Brook RD, Brook AJ, Jamerson K, Levy PD, Kaciroti N. J Am Heart Assoc, 2023 Jul 18; 12 (14): e030696 DOI:10.1161/JAHA.123.030696
      PMID: 37421293
    • Journal Article
      Comparing six cardiovascular risk prediction models in Haiti: implications for identifying high-risk individuals for primary prevention
      Yan LD, Lookens Pierre J, Rouzier V, Théard M, Apollon A, St Preux S, Kingery JR, Jamerson KA, Deschamps M, Pape JW, Safford MM, McNairy ML. 2022 Mar 19; DOI:10.7302/5244
    • Proceeding / Abstract / Poster
      Abstract P102: Comparison Of Existing Cardiovascular Risk Prediction Models In Haiti: Implications For Primary Prevention In Lower-income Countries
      Yan LD, Lookens Pierre J, Rouzier V, Théard M, Apollon A, St-Preux S, Kingery J, Jamerson KA, Deschamps M, Pape JW, Safford MM, Mcnairy M. Circulation, 2022 Mar; 145 (Suppl_1): DOI:10.1161/circ.145.suppl_1.p102
    • Journal Article
      Self-Reported Antihypertensive Medication Class and Temporal Relationship to Treatment Guidelines.
      Egan BM, Yang J, Rakotz MK, Sutherland SE, Jamerson KA, Wright JT, Ferdinand KC, Wozniak GD. Hypertension, 2022 Feb; 79 (2): 338 - 348. DOI:10.1161/HYPERTENSIONAHA.121.17102
      PMID: 34784722